<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Meeting id="1702592" title="Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial"><ConferenceName>2015 European Cancer Organisation Congress</ConferenceName><StartDate>2015-09-25T00:00:00Z</StartDate><EndDate>2015-09-29T00:00:00Z</EndDate><City>Vienna</City><Country>Austria</Country></Meeting>